We are live on
!
Find out more
CCM
Cullen Capital Management Portfolio holdings
AUM
$9.75B
1-Year Est. Return
21.81%
This Fund
S&P 500
This Quarter
Est. Return
+1.5%
1 Year Est. Return
+21.81%
3 Year Est. Return
+48.84%
5 Year Est. Return
+62.4%
10 Year Est. Return
+166.06%
AUM
$11.2B
AUM Growth
+$273M
(+2.5%)
Cap. Flow
+$141M
Cap. Flow
% of AUM
1.26%
Top 10 Holdings %
Top 10 Hldgs %
24.72%
Holding
306
New
31
Increased
125
Reduced
109
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baxter International
BAX
|
+$51.7M |
| 2 |
General Dynamics
GD
|
+$35M |
| 3 |
Coca-Cola Europacific Partners
CCEP
|
+$34.5M |
| 4 |
State Street Real Estate Select Sector SPDR ETF
XLRE
|
+$26M |
| 5 |
VE
VEOLIA ENVIRONNEMENT
VE
|
+$22.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$66.4M |
| 2 |
Intel
INTC
|
+$41.6M |
| 3 |
Broadcom
AVGO
|
+$37.9M |
| 4 |
Kontoor Brands
KTB
|
+$33.2M |
| 5 |
Vale
VALE
|
+$31.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.85% |
| 2 | Financials | 12.46% |
| 3 | Consumer Staples | 11.21% |
| 4 | Industrials | 11.01% |
| 5 | Technology | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
AbbVie
ABBV
$429B
| $462K | ﹤0.01% |
3,432
| – | – |
|
152
Amgen
AMGN
$209B
| $444K | ﹤0.01% |
1,998
-183
| -8% | -$42.5K |
|
153
Linde
LIN
$222B
| $442K | ﹤0.01% |
1,160
| – | – |
|
154
Western Alliance Bancorporation
WAL
$9.3B
| $442K | ﹤0.01% |
12,106
+3,915
| +48% | +$136K |
|
155
iShares MSCI EAFE ETF
EFA
$79.3B
| $441K | ﹤0.01% |
6,086
+872
| +17% | +$63.3K |
|
156
iShares MSCI ACWI ex US ETF
ACWX
$11.7B
| $439K | ﹤0.01% |
+8,918
| New | +$439K |
|
157
Royal Bank of Canada
RY
$291B
| $433K | ﹤0.01% |
4,535
-340
| -7% | -$32.5K |
|
158
Unisys
UIS
$222M
| $400K | ﹤0.01% |
100,502
+26,674
| +36% | +$106K |
|
159
W.P. Carey
WPC
$16.5B
| $382K | ﹤0.01% |
5,774
-1,184
| -17% | -$82.3K |
|
160
State Street Technology Select Sector SPDR ETF
XLK
$123B
| $357K | ﹤0.01% |
+4,106
| New | +$324K |
|
161
Rayonier
RYN
$6.54B
| $336K | ﹤0.01% |
11,808
| – | – |
|
162
American Water Works
AWK
$26.5B
| $329K | ﹤0.01% |
2,303
+436
| +23% | +$64K |
|
163
Select Water Solutions
WTTR
$2.29B
| $323K | ﹤0.01% |
39,855
+8,757
| +28% | +$66.2K |
|
164
Steven Madden
SHOO
$3.58B
| $314K | ﹤0.01% |
9,608
+1,725
| +22% | +$57.5K |
|
165
Seagate
STX
$198B
| $308K | ﹤0.01% |
+4,982
| New | +$304K |
|
166
HF Sinclair
DINO
$15.7B
| $300K | ﹤0.01% |
6,729
-1,053
| -14% | -$45.9K |
|
167
SouthState Bank Corp
SSB
$10.6B
| $290K | ﹤0.01% |
4,413
-723
| -14% | -$48.3K |
|
|
PFC
168
DELISTED
Premier Financial Corp. Common Stock
PFC
| $289K | ﹤0.01% |
18,028
+2,880
| +19% | +$47.3K |
|
|
PCH
169
DELISTED
PotlatchDeltic
PCH
| $283K | ﹤0.01% |
5,346
| – | – |
|
170
Carrier Global
CARR
$54.2B
| $278K | ﹤0.01% |
5,588
-85
| -1% | -$3.74K |
|
171
Forrester Research
FORR
$228M
| $271K | ﹤0.01% |
+9,321
| New | +$277K |
|
172
State Street Energy Select Sector SPDR ETF
XLE
$38.4B
| $264K | ﹤0.01% |
+6,510
| New | +$265K |
|
173
Wendy's
WEN
$1.45B
| $259K | ﹤0.01% |
+11,900
| New | +$265K |
|
174
TAL Education Group
TAL
$6.67B
| $255K | ﹤0.01% |
111,423
-15,000
| -12% | -$89.8K |
|
175
Columbia Sportswear
COLM
$2.95B
| $252K | ﹤0.01% |
3,262
+380
| +13% | +$30.6K |
|
Similar funds
FCM
URS
MPI
HL
DCP
CIM
MF
HI
Cullen Capital Management's Q2 2023 Portfolio in Review
As of Q2 2023, Cullen Capital Management held 306 positions worth $11.2B, up 2.5% from $10.9B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Cullen Capital Management's Q2 2023 filing shows 31 new, 125 increased, 109 reduced and 12 closed positions. Its largest new stake was Baxter International: 1,188,029 shares worth $54.1M. The largest sale was Novartis, an estimated $66.4M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 13% a quarter earlier, followed by Financials and Consumer Staples.
- Cullen Capital Management's largest Q2 2023 buy was Baxter International: 1,188,029 shares worth $54.1M.
- Cullen Capital Management added most to General Dynamics in Q2 2023, an estimated $35M increase.
- Cullen Capital Management's biggest Q2 2023 reduction was Novartis, cutting an estimated $66.4M.
- Cullen Capital Management fully exited UBS Group in Q2 2023, selling an estimated $1.38M.
- Cullen Capital Management's ten largest holdings make up 25% of its $11.2B portfolio in Q2 2023.
- Cullen Capital Management opened 31 new positions and closed 12 in Q2 2023.
- Cullen Capital Management's portfolio value rose 2.5% quarter-over-quarter to $11.2B.
Based on Cullen Capital Management's 13F filing for Q2 2023, filed 15 Aug 2023.